UNSPSC 51385808: Piroxicam olamine

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C15H13N3O4S.C2H7NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier T4O2MP4507, chemically known as 2h-1,2-benzothiazine-3-carboxamide, 4-hydroxy-2-methyl-n-2-pyridinyl-,1,1-dioxide, compd with 2-aminoethanol (1:1) but more generally known as piroxicam olamine, which bears US NIH Compound Identifier 5745802.

UNSPSC 51385808 Piroxicam olamine, a Commodity code, shows a significant mismatch between its nominal scope and state and local procurement activity. Piroxicam olamine is a nonsteroidal anti-inflammatory drug (NSAID) preparation, yet the single recent opportunity tagged under this code — Seminole County, Florida's IFB 60459723LAS — solicits naloxone and drug deactivation systems, products unrelated to the pharmaceutical compound the code nominally describes. The opportunity represents public-health procurement by a county health authority rather than pharmaceutical supply sourcing aligned with the code's stated commodity.

Seminole County's June 2026 posting (with a July 2026 response deadline) seeks 1,900 units of naloxone and 800 safe drug deactivation systems annually on a two-year initial term with a one-year renewal option, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. Vendors must handle all shipping and delivery costs, maintain drug-free workplace and E-Verify compliance, and carry workers' compensation, commercial general liability, and professional liability insurance. The procurement may be FEMA-funded and includes a three-month probationary termination clause. The code shows little relevant recent activity; the single indexed opportunity reflects a tagging error rather than a pattern of state and local demand for piroxicam olamine itself.